Pulmonary fibrosis (PF), which comprises several subtypes including idiopathic PF and progressive PF, significantly impacts patients' quality of life as a result of lung function impairment. Management of PF is challenging as treatment options have historically been limited; however, recent advances in the understanding of underlying inflammatory and fibrotic processes have prompted investigation into several novel therapeutic targets. Join us as we dive into the evolving pharmacologic landscape for PF and discuss strategies for clinical decision-making in light of these pivotal developments. This engaging webinar will be led by renowned pulmonology experts and will feature an overview of an interactive 3D medical animation which provides scientifically accurate visual depictions of key mediators in PF pathogenesis.